Atlas Trials

β-globin Restored Autologous HSC in β-thalassemia Major Patients

Clinical trial NCT04205435 · TERMINATED

Trial details

NCT number
NCT04205435
Sponsor
Bioray Laboratories
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
β-thalassemia Major
Start date
2021-11-01
Primary completion
2022-06-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.